Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.31 |
| ▸ | SLC2A3 | P11169 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17057794 | 0.91 | SLC2A1 (0.32) | SLC2A1SLC2A3 | |
| SCHEMBL17058188 | 0.88 | NPC1 (0.39) | SLC2A1SLC2A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17058048 | 0.87 | PDE4A (0.35) | SLC2A1SLC2A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11945609 | 0.85 | MAPT (0.38) | SLC2A1SLC2A3 | |
| SCHEMBL17058122 | 0.85 | NPC1 (0.35) | SLC2A1SLC2A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17058167 | 0.82 | NPBWR1 (0.37) | MCHR1 | |
| SCHEMBL17057874 | 0.82 | NPC1 (0.40) | SLC2A1SLC2A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17058038 | 0.82 | NPBWR1 (0.36) | SMN1; SMN2MCHR1 | |
| SCHEMBL17057984 | 0.81 | FFAR4 (0.32) | GRM7 | |
| SCHEMBL17057951 | 0.81 | SLC2A1 (0.34) | SLC2A1SLC2A3NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137179-B1 | PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS | MERCK SHARP & DOHME (US) | 2015-09-02 | — | — | EP | disclosed |